Company Analysis

Citius Pharmaceuticals, Inc. (CTXR)

Nasdaq: CTXR · Pharmaceutical Preparations · Cranford, NJ · filing with the SEC since 2010
Grade3.6
◀ Past 5.2● Present 3.1▶ Future 3.0
3 est.

Filings

424 filings since 2017 beside 113 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Dec 29, 2026
10-Q Quarterly report for the quarter ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Feb 14, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 118 days after the quarter ended. The proxy statement was last filed Feb 24, 2026.

Filings a yearinsider forms included
5078753833634130
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 6 times in the last 36 months, the newest Aug 21, 2026.SEC letters: 4 in the last 36 months, the newest Aug 10, 2026.
Insider forms 113

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 4, 2026 8-K items 8.01, 9.01 Other event · Current report
Oct 26, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 21, 2026 8-K item 3.01 Listing warning from its exchange · Current report Aug 17, 2026
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 14, 2026 10-Q Quarterly report Jun 30, 2026
Aug 14, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 10, 2026 UPLOAD SEC comment letter
Aug 5, 2026 8-K items 8.01, 9.01 Other event · Current report
Jun 4, 2026 SCHEDULE 13D/A Activist holder update, amended
Jun 2, 2026 EFFECT Registration effective
Jun 1, 2026 8-K items 8.01, 9.01 Other event · Current report
May 29, 2026 CORRESP Reply to the SEC
May 22, 2026 S-3 Shelf registration
May 15, 2026 8-K items 2.02, 9.01 Results released · Current report
May 15, 2026 10-Q Quarterly report Mar 31, 2026
May 8, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report May 4, 2026
Apr 29, 2026 8-K items 3.02, 8.01, 9.01 Shares sold without registration; Other event · Current report Apr 23, 2026
Apr 24, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Apr 23, 2026
Apr 24, 2026 424B5 Shelf offering
Apr 6, 2026 8-K item 5.07 Shareholder vote · Current report
Mar 31, 2026 8-K items 8.01, 9.01 Other event · Current report
Mar 10, 2026 8-K items 8.01, 9.01 Other event · Current report
Mar 4, 2026 8-K items 8.01, 9.01 Other event · Current report
Feb 24, 2026 ARS Annual report to shareholders Sep 30, 2025
Feb 24, 2026 DEFA14A Extra proxy material
Feb 24, 2026 DEF 14A Proxy statement Apr 6, 2026
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 13, 2026 8-K items 2.02, 3.01, 9.01 Results released; Listing warning from its exchange · Current report Feb 9, 2026
Feb 13, 2026 10-Q Quarterly report Dec 31, 2025
Jan 28, 2026 10-K/A Annual report, amended Sep 30, 2025
Dec 23, 2025 8-K items 2.02, 9.01 Results released · Current report
Dec 23, 2025 10-K Annual report Sep 30, 2025
Dec 17, 2025 SCHEDULE 13D/A Activist holder update, amended
Dec 1, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Oct 27, 2025 SCHEDULE 13G Large holder notice
Oct 23, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Oct 21, 2025 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Oct 20, 2025
Oct 21, 2025 424B5 Shelf offering
Sep 12, 2025 SCHEDULE 13D/A Activist holder update, amended
Aug 12, 2025 8-K items 2.02, 9.01 Results released · Current report
40 of 424 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton CTXR · research, not advice